![Isaac Stoner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Isaac Stoner
Directeur Général chez
Mindimmune Therapeutics, Inc.
Profil
Mr. Isaac Stoner is a Chief Executive Officer & Director at Mindimmune Therapeutics, Inc. He is on the Board of Directors at Mindimmune Therapeutics, Inc. Mr. Stoner was previously employed as a President, Chief Executive Officer & Director by Octagon Therapeutics, Inc. He received his undergraduate degree from Brown University and an MBA from MIT Sloan School of Management.
Postes actifs de Isaac Stoner
| Sociétés | Poste | Début |
|---|---|---|
Mindimmune Therapeutics, Inc.
 Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Directeur Général | 24/11/2025 |
Anciens postes connus de Isaac Stoner
| Sociétés | Poste | Fin |
|---|---|---|
Octagon Therapeutics, Inc.
 Octagon Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotics and medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells | Directeur Général | 02/01/2025 |
Formation de Isaac Stoner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Brown University
 Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mindimmune Therapeutics, Inc.
Mindimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs that target immune system for treating diseases related to central nervous system | Health Technology |
Octagon Therapeutics, Inc.
Octagon Therapeutics, Inc. BiotechnologyHealth Technology Develops antibiotics and medicines based on novel metabolic targets in disease-causing bacteria, lymphocytes, and cancer cells | Health Technology |
